ArticleMedical science monitor : international medical journal of experimental and clinical research2022

Efficacy of PD-1 Inhibitor Combined with Bevacizumab in Treatment of Advanced Endometrial Cancer Patients with Mismatch Repair Deficiency (dMMR)/High-Level Microsatellite Instability (MSI-H).

Ying Liao et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.